17th Oct 2014 15:56
17 October 2014
Directors' Dealings
Sinclair IS Pharma plc (SPH.L), ("Sinclair" or the "Group") the international specialty pharma company, was informed on 17 October 2014 earlier that day Jean-Charles Tschudin, a Non-Executive Director, acquired 500,000 ordinary shares in Sinclair at an average price of 28.75p per share. Following this purchase Jean-Charles Tschudin has a beneficial interest in 3,000,117 ordinary shares representing 0.60% of the Group's issued ordinary share capital.
For further information, please contact:
Sinclair IS Pharma plc Tel: +44 (0) 20 7467 6920
Chris Spooner
Alan Olby
Peel Hunt LLP Tel: +44 (0) 20 7418 8900
James Steel
Clare Terlouw
Related Shares:
Sinclair Pharma